High technology interventions near the end of life exact a high cost both in human and economic terms.
Breathtaking advances in cardiology have helped to prolong life and improve its quality for many.
For some, it has transformed the process of dying into a medical nightmare.
The « do everything possible » attitude that prevailed during the past few decades is both inhumane and wasteful.
In contrast, in the new era of managed care with its focus on profit, a well meaning physician may become suspect whenever he recommends against a medical intervention that he deems to be futile.
More than ever before, there is a pressing need to develop rational guidelines for end of life medical interventions to ensure primacy of patients'best interests, protect the integrity of the doctor-patient relationship and affirm the duty of the medical establishment toward society at large.
This weighty issue must not be relinquished to medical ethicists, health care alliances or the courts.
It is the domain of physicians and the public at large.
Medical futility should be defined as a treatment unlikely to affect the course of illness or that which has failed to achieve its desired effects.
Rational guidelines for cardiopulmonary resuscitation and do not resuscitate orders should be formulated for both inhospital and out of hospital victims of cardiac arrest. (...)
Mots-clés Pascal : Extrémité, Vie physiologique, Technologie avancée, Ethique, Economie santé, Guide, Traitement, Homme
Mots-clés Pascal anglais : End, Life (physiology), Advanced technology, Ethics, Health economy, Guide, Treatment, Human
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 97-0030383
Code Inist : 002B31. Création : 21/05/1997.